BackChromocell Therapeutics Overview

Chromocell Therapeutics Common Stock

Chromocell Therapeutics's common stock is $0.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$0.00
↓ 100.00% YoYΔ $-67.00 vs prior year quarter

Peer trimmed avg / median

Loading

Chromocell Therapeutics Common Stock History

Loading

Chromocell Therapeutics vs. peers: Common Stock Comparison

Loading

Chromocell Therapeutics Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Chromocell Therapeutics (CHRO) FAQ

As of the most recent data (June 2026), CHRO shows a common stock of $0. That compares with $67 in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CHRO's common stock is now $0 (was $67) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Chromocell Therapeutics is outperforming or lagging.

Tracking CHRO's common stock over time shows whether Chromocell Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $67 in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Chromocell Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $0) with ownership activity and broader fundamentals.